Life Sciences Virtual Investor Forum Agenda
Analysis based on 12 articles · First reported Sep 14, 2026 · Last updated Sep 15, 2026
The announcement is a routine investor-relations scheduling notice and is unlikely to move broad market indices or sector valuations on its own. Any price impact would be limited to the individual presenting micro- and small-cap life sciences names, and only if they disclose material pipeline or business updates during the September 17 sessions.
Virtual Investor Conferences, a proprietary investor conference series, announced on September 14, 2026 the agenda for its upcoming Life Sciences Virtual Investor Forum, scheduled for September 17, 2026 in New York. The online event is designed to connect individual investors, institutional investors, advisors, and analysts with clinical-stage and commercial life sciences companies. There is no admission fee for live presentations or for scheduling one-on-one meetings with company management. Greg Young, VP of Corporate Services at OTC Markets Group, said the forum gives these companies an efficient platform to share pipeline updates and engage directly with a global investor audience. The announced presentation lineup, with times in ET, is Avicanna Inc. at 10:30 AM, Sona Nanotech Inc. at 11:00 AM, Rafael Pharmaceuticals Inc. at 11:30 AM, Adaptimmune Therapeutics, Inc. at 1:00 PM, Amplia Therapeutics Ltd. at 2:00 PM, Altrova Health Inc. at 2:30 PM, CytoDyn Inc. at 3:30 PM, and 4DMedical Limited Ltd. at 4:00 PM. Attendees are encouraged to pre-register and run an online system check to expedite participation and receive event updates. The forum is a routine investor-relations engagement rather than a market-moving development, and no financial results, capital raises, or clinical data were disclosed in the announcement.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard